Yes, 100%
Previously we were told:
43:28, Andrew Purcell: “There’s no interruption to drill A3 next. Well’s take a while to permit up. Casing has to be bought months in advance. Drill programs have to be agreed with the regulator and drill contractors, so A3s happening next…”https://www.youtube.com/watch?v=ZWsdnBJTxOM&ab_channel=InvestorStream Investor Stream Webinar Series: Melbana Energy (ASX:MAY) Investor Briefing (August 28, 2023)
It is a bit puzzling, there are quite a few possible explanations like 1) maybe they did get their hands on an artificial lift, 2) maybe they thought Alameda-3 would take too long (they might have wanted a catalyst before the 16/11/2023 AGM [for some unknown reason wink wink], 3) etc etc etc...
The point is, it is was not the plan, and even after Alameda-2 finished, and when they were presenting all their information Andrew Purcell still said "There’s no interruption to drill A3 next." He said A3 is what excites the shareholders as a response to why the share price is still low... and yet here we are.
- Forums
- ASX - By Stock
- MAY
- Ann: 2023 Annual Report to Shareholders
Ann: 2023 Annual Report to Shareholders, page-52
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MAY (ASX) to my watchlist
|
|||||
Last
2.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.14M |
Open | High | Low | Value | Volume |
2.2¢ | 2.2¢ | 2.1¢ | $19.86K | 908.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 1717602 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 334233 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 1717602 | 0.021 |
28 | 5356419 | 0.020 |
10 | 1046920 | 0.019 |
3 | 358730 | 0.018 |
3 | 3030005 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 334233 | 6 |
0.023 | 1500000 | 4 |
0.024 | 2512742 | 6 |
0.025 | 1366441 | 6 |
0.026 | 715955 | 4 |
Last trade - 15.50pm 13/08/2024 (20 minute delay) ? |
Featured News
MAY (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online